Therese Abraham
Medical · Glendale, CANPI 1063726586
Payments from drug & device makers
Across 114 payments — averaging $26.01 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$622
- Novo Nordisk$331
- GSK$273
- Pfizer$214
- Lilly USA, LLC$211
- Salix Pharmaceuticals, A Division Of Bausch Health US, LLC$169
- plus $1K from 23 others
What the payments were for
- Food & beverage$2,965100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie | 27 | $622 |
| Novo Nordisk | 6 | $331 |
| GSK | 9 | $273 |
| Pfizer | 9 | $214 |
| Lilly USA, LLC | 9 | $211 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 8 | $169 |
| Amgen | 8 | $166 |
| Novartis | 6 | $140 |
| Abbott | 1 | $110 |
| Aimmune Therapeutics, Inc. | 3 | $76 |
| Sanofi-aventis U.S. LLC | 3 | $72 |
| Merck | 3 | $64 |
| Ardelyx, Inc. | 2 | $59 |
| Shield Therapeutics Inc | 2 | $49 |
| Amarin Pharma, Inc. | 2 | $41 |
| Stryker | 1 | $38 |
| Exact Sciences | 1 | $31 |
| Xeris Pharmaceuticals, Inc. | 2 | $31 |
| Regeneron Healthcare Solutions, Inc. | 1 | $29 |
| Hologic Sales And Service, LLC | 1 | $29 |
| Krystal Biotech Inc | 1 | $27 |
| Phadia US Inc. | 2 | $27 |
| Ironwood Pharmaceuticals, Inc | 1 | $24 |
| Sumitomo Pharma America, Inc. | 1 | $23 |
| Gilead | 1 | $23 |
| Boehringer Ingelheim | 1 | $22 |
| Biohaven Pharmaceuticals, Inc. | 1 | $22 |
| Nevro Corp. | 1 | $22 |
| Nestle Healthcare Nutrition Inc. | 1 | $21 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Ozempic$250
- FREESTYLE LIBRE 3$110
How this compares
$2,965 in reported general payments places this provider in the 80th percentile of 2,087 medical providers in California.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| JardianceEmpagliflozin | 118 | $93,198 |
| OzempicSemaglutide | 38 | $42,193 |
| LinzessLinaclotide | 55 | $33,385 |
| JanumetSitagliptin Phos/Metformin Hcl | 62 | $33,053 |
| MyrbetriqMirabegron | 39 | $19,478 |
| JanuviaSitagliptin Phosphate | 19 | $18,287 |
| ZenpepLipase/Protease/Amylase | 16 | $13,335 |
| VascepaIcosapent Ethyl | 63 | $13,055 |
| Synjardy XrEmpagliflozin/Metformin Hcl | 13 | $11,010 |
| SynjardyEmpagliflozin/Metformin Hcl | 17 | $10,163 |
| Breo ElliptaFluticasone/Vilanterol | 17 | $6,611 |
| Basaglar Kwikpen U-100Insulin Glargine,hum.Rec.Anlog | 20 | $5,254 |
| DuleraMometasone/Formoterol | 13 | $4,380 |
| Arnuity ElliptaFluticasone Furoate | 16 | $3,403 |
| Dexlansoprazole DrDexlansoprazole | 15 | $3,125 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Boehringer IngelheimJardiance, Synjardy Xr, Synjardy | $22 | $114,371148 claims |
| MerckJanumet, Januvia, Dulera | $64 | $55,72094 claims |
| Novo NordiskOzempic | $331 | $42,19338 claims |
| AbbVieLinzess | $622 | $33,38555 claims |
| Aimmune Therapeutics, Inc.Zenpep | $76 | $13,33516 claims |
| GSKBreo Ellipta, Arnuity Ellipta | $273 | $10,01433 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 80th percentile of 2,087 medical providers in California.
Other medical in Glendale
- Nicola LowreyOrange$655K
- Justin LoveLoma Linda$553K
- David DoriguzziLancaster$514K
- Alison GracomIrvine$467K
- Jeffrey BonnaudLos Angeles$314K
- Ana TorresLaguna Beach$229K
- Heather ParlettRedlands$168K
- Deirdre MoxleyFullerton$149K
- Tri leGardena$127K
- Linda RankLadera Ranch$105K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.